Obsidian Therapeutics
PrivateLast Round
Private Equity
Apr 14, 2026
Est. Valuation
$763.5M
Total Funding Raised
$325M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Obsidian Therapeutics is a biotechnology company that develops engineered cell and gene therapies for cancer treatment using a proprietary protein-regulation platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Obsidian Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Obsidian Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Apr 14, 2026 | ||||
| Series C | Apr 3, 2024 | ||||
| Series B | Sep 9, 2021 | ||||
| Series A | Dec 6, 2017 |
Obsidian Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | Private Equity |
| Soleus Capital | Series B |
| Surveyor Capital | Series C, Series B |
| Janus Henderson Group | Series C, Private Equity |
| Balyasny Asset Management L.P. | Private Equity |
| RA Capital Management | Series C, Series B, Private Equity |
| TCG Crossover | Series C, Private Equity, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
All-stock merger agreement with Galera Therapeutics announced.
- Apr 14, 2026
$350M raised in a Private Placement round.
Obsidian Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Obsidian Therapeutics's valuation, stock price, and market status.